Microbix Biosystems Inc. (TSX:MBX)
Canada · Delayed Price · Currency is CAD 0.3000
+0.0100 (3.45%)
Aug 10, 2026, 3:20 PM EST
Microbix Biosystems Ratios and Metrics
Market cap in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 40 | 37 | 46 | 42 | 71 | 80 | |
Market Cap Growth | 0.11% | -19.43% | 7.96% | -40.15% | -10.97% | 181.52% |
Enterprise Value | 38.62 | 31.56 | 39.23 | 37.47 | 63.22 | 77.37 |
Last Close Price | 0.30 | 0.27 | 0.34 | 0.31 | 0.51 | 0.63 |
PE Ratio | - | - | 12.88 | - | 39.23 | 24.23 |
Forward PE | - | 21.67 | 16.75 | 17.43 | 20.40 | 13.70 |
PS Ratio | 2.70 | 1.99 | 1.80 | 2.57 | 3.72 | 4.28 |
PB Ratio | 1.59 | 1.33 | 1.62 | 1.72 | 2.84 | 4.29 |
P/TBV Ratio | 1.92 | 1.53 | 1.93 | 2.12 | 3.08 | 5.28 |
P/FCF Ratio | - | - | 16.89 | - | 49.24 | 92.16 |
P/OCF Ratio | - | - | 10.53 | - | 20.46 | 37.79 |
EV/Sales Ratio | 2.61 | 1.70 | 1.54 | 2.27 | 3.31 | 4.16 |
EV/EBITDA Ratio | - | 428.20 | 7.11 | - | 17.34 | 13.67 |
EV/EBIT Ratio | - | - | 10.05 | - | 24.22 | 16.00 |
EV/FCF Ratio | - | - | 14.47 | - | 43.92 | 89.55 |
Debt / Equity Ratio | 0.23 | 0.24 | 0.22 | 0.26 | 0.22 | 0.27 |
Debt / EBITDA Ratio | - | 91.91 | 1.16 | - | 1.60 | 1.37 |
Debt / FCF Ratio | - | - | 2.36 | - | 4.05 | 8.95 |
Net Debt / Equity Ratio | -0.05 | -0.19 | -0.23 | -0.20 | -0.31 | -0.12 |
Net Debt / EBITDA Ratio | 0.41 | -72.42 | -1.19 | 1.07 | -2.10 | -0.40 |
Net Debt / FCF Ratio | 0.24 | 6.08 | -2.42 | 2.35 | -5.32 | -2.61 |
Asset Turnover | 0.41 | 0.49 | 0.69 | 0.48 | 0.62 | 0.84 |
Inventory Turnover | 0.88 | 1.12 | 1.64 | 1.64 | 1.64 | 1.74 |
Quick Ratio | 2.77 | 4.94 | 5.05 | 3.63 | 6.25 | 2.73 |
Current Ratio | 5.35 | 8.48 | 7.15 | 5.13 | 8.45 | 3.68 |
Return on Equity (ROE) | -22.11% | -8.01% | 13.30% | -0.16% | 8.22% | 25.69% |
Return on Assets (ROA) | -14.11% | -4.29% | 10.20% | -16.90% | 8.23% | 21.77% |
Return on Invested Capital (ROIC) | -21.08% | -7.33% | 18.18% | -31.48% | 15.19% | 33.35% |
Return on Capital Employed (ROCE) | -15.68% | -4.92% | 11.83% | -18.82% | 9.64% | 27.53% |
Earnings Yield | - | - | 7.76% | 0.00% | 2.55% | 4.13% |
FCF Yield | - | - | 5.92% | - | 2.03% | 1.09% |
Buyback Yield / Dilution | 0.80% | -0.48% | -0.42% | 2.67% | -0.00% | -26.40% |
Total Shareholder Return | 0.80% | -0.48% | -0.42% | 2.67% | -0.00% | -26.40% |